4
Changes in Ownership
Solid Biosciences Inc. Filed Acc 0001193125-26-034076
Chief Technology Officer sold 26,250 shares at $6.44 ($168,969)
- Chief Technology Officer acquired 79,600 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Herzich Paul Chief Technology Officer | 2026-01-29 | Option exercise 10b5-1 | +54,925 | 81,547 | D | ||
| Herzich Paul Chief Technology Officer | 2026-01-31 | Option exercise 10b5-1 | +24,675 | 106,222 | D | ||
| Herzich Paul Chief Technology Officer | 2026-02-02 | Sale 10b5-1 | −26,250 | $6.44 | $168,969 | 79,972 | D |
| Derivatives | |||||||
| Herzich Paul Chief Technology Officer | 2026-01-29 | Option exercise · Performance Stock Units 10b5-1 | −54,925 | 0 | D | ||
| Herzich Paul Chief Technology Officer | 2026-01-29 | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +170,000 | 170,000 | D | ||
| Herzich Paul Chief Technology Officer | 2026-01-29 | Grant or award · Restricted Stock Units 10b5-1 | +85,000 | 85,000 | D | ||
| Herzich Paul Chief Technology Officer | 2026-01-31 | Option exercise · Restricted Stock Units 10b5-1 | −24,675 | 74,025 | D | ||
| Open-market sales · 26,250 sh · avg $6.44 · $168,969 | |||||||
Loading xslF345X05/ownership.xml…